Update

RNS Number : 9791S

Integumen PLC

29 June 2018

 

29 June 2018

Integumen plc

("Integumen" or "the Company")

Update

The Company provides an update further to the announcement dated 16 April 2018.

Discussions with Cellulac and due diligence are ongoing, as is the process of raising funds for the proposed transaction and the Company's ongoing requirements. 

The Company is required to publish its accounts for the year ended 31 December 2017 ("2017 Accounts") by 30 June 2018 under Rule 19 of the AIM Rules for Companies.  However, the Board  anticipates that completion of the audit, and publication of the 2017 Accounts, will now take place following the announcement of the fundraising or the Transaction.

Further updates will be made as required.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

Integumen plc	Tony Richardson, Chairman	+ 353 (0) 87 770 5506
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Andrew Emmott	[phone]
Hybridan LLP  (Broker)	Claire Noyce	[phone]
Turner Pope Investments (TPI) Ltd (Broker)	Ben Turner/James Pope	[phone]
Cardew Group	Shan Shan Willenbrock Joe McGregor	[phone] Mail to [e-mail]

 

END

 

 

UPDEAXKPADEPEFF